Novel Polyfunctional Pyridines as Anticancer and Antioxidant Agents. Synthesis, Biological Evaluation and in Silico ADME-T Study
Open Access
- 1 January 2017
- journal article
- Published by Pharmaceutical Society of Japan in Chemical and Pharmaceutical Bulletin
- Vol. 65 (5) , 442-454
Abstract
Two series of novel alkoxylated 2-oxo(imino)-3-pyridinecarbonitriles (structurally-relevant to some reported anticancer pyridines with phosphodiesterase 3A (PDE3A) inhibitory activity) were synthesized and evaluated for their in vitro differential tumor cell growth inhibitory potential against the breast MCF7, hepatocellular Hep-G2, colon CACO-2 cell lines, and a normal human foreskin fibroblast Hs27 cell line. Compounds 8, 16 and 19 displayed recognizable growth inhibitory ability and selectivity towards the breast MCF7 (LC50 19.15, 17.34 and 14.70 µM, respectively) as compared with doxorubicin (LC50 3.94 µM). Meanwhile, compounds 8, 15, 16, and 19 revealed a marginal inhibitory effect on the growth of the normal human foreskin fibroblast Hs27 cell line, beside a distinctive antioxidant potential in the 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay. These four compounds were further assessed for their in vitro inhibition of PDE3A (a current antitumor therapeutic target), where 16 and 19 showed moderate to weak PDE3A inhibitory as compared with milrinone, the positive control. No clear straightforward liaison between the anticancer potential and PDE3A inhibitory activity could be deduced. Computations of the predicted pharmacokinetic properties, toxicity effects (ADME-T), drug-likeness and drug scores for the newly developed compounds showed non-violations of Lipinski's RO5 and Veber's criteria for good bioavailability, with a predicted high safety profile.Keywords
This publication has 56 references indexed in Scilit:
- Synthesis and characterization of some hydroxypyridone derivatives and their evaluation as antimicrobial agentsJournal of Enzyme Inhibition and Medicinal Chemistry, 2012
- Discovery of colon tumor cell growth inhibitory agents through a combinatorial approachEuropean Journal of Medicinal Chemistry, 2010
- Targeting cancer with phosphodiesterase inhibitorsExpert Opinion on Investigational Drugs, 2009
- Green chemoselective synthesis of thiazolo[3,2-a]pyridine derivatives and evaluation of their antioxidant and cytotoxic activitiesBioorganic & Medicinal Chemistry Letters, 2009
- Reactive Oxygen Species, Cancer and Anti-Cancer TherapiesCurrent Chemical Biology, 2009
- Methoxylated flavones, a superior cancer chemopreventive flavonoid subclass?Seminars in Cancer Biology, 2007
- Discovery of a novel small molecule binding site of human survivinBioorganic & Medicinal Chemistry Letters, 2007
- 14β-Hydroxy-10-deacetylbaccatin III as a convenient, alternative substrate for the improved synthesis of methoxylated second-generation taxanesBioorganic & Medicinal Chemistry Letters, 2006
- Isoforms of Cyclic Nucleotide Phosphodiesterase PDE3A in Cardiac MyocytesJournal of Biological Chemistry, 2002
- Molecular Properties That Influence the Oral Bioavailability of Drug CandidatesJournal of Medicinal Chemistry, 2002